Event Carousel Image

WE BELIEVE IN THE POWER
OF PARTNERSHIPS.

#POWEROFPARTNERSHIPS

WE DON'T REPORT THE DAILY NEWS.

WE COLLABORATE WITH LEADING MINDS TO HELP COMMERCIALISE ADVANCED THERAPIES

#POWEROFPARTNERSHIPS

 

Event Carousel Image

WE GET TO

CHANGE AND INSPIRE

OUR WORLD.

#POWEROFPARTNERSHIPS

WE WORK TOGETHER TO

IMPROVE DISRUPT AND DRIVE

THE FUTURE OF ADVANCED

THERAPIES.

#POWEROFPARTNERSHIPS

Phacilitate Exchange

Editor's Pick

Featured content image

Cell and Gene Therapy Manufacturing Capacities in Europe 2017

Without capacity; manufacturing expertise; innovation and partnerships, advanced therapies cannot be commercialised nor ... read more
Featured content image

WEBINAR SERIES: Funding, Commercialisation and Market Access for Advanced Therapies

This webinar series has been co-organised by Phacilitate and Biotech and Money/LSX

Featured content image

Increasing Access to Cell and Gene Therapies: The Potential of Outcome-based Annuity Payments

Could outcome-based annuity payments, in which cell and gene therapies are paid for over-time as benefits materialise, i... read more

Featured Videos

Play button Featured content image

Video: Striking the Balance Between Regulatory Opportunities and Challenges

A video interview with Peter Olaganju, Senior Technical Director at Bluebird Bio. With every new opportunity comes great... read more
Play button Featured content image

Video: How to Deliver Innovative Immunotherapies to Patients in the 'Real World'

The infrastructure of delivering immuno-oncology therapies is equal in importance to the science. the industry must deve... read more
Play button Featured content image

Video: Advanced Therapies 2025

Industry leaders discuss the past, present and future of advanced therapies in this inspiring video...